About RCM
Company Overview
RCM, operating the domain rexcapitals.com, is a financial entity registered in Hong Kong. According to public records, the company was established on 28 April 2020. However, independent public information about its operations, ownership, and management is extremely limited.
FXCanary could not find any official website content or marketing materials for this broker. This lack of transparency raises immediate caution for potential traders. Without access to the broker’s own statements, it is impossible to verify its offerings or credibility.
Regulatory Status
Our review found that RCM holds no recognised regulatory licence from any major financial authority. The only known registration is a corporate filing in Hong Kong, which does not grant permission to offer financial services or hold client funds.
For traders, engaging with an unregulated broker carries significant risks. There are no safeguards such as negative balance protection, client fund segregation, or access to an independent ombudsman. The absence of regulation is a critical red flag.
Risk Assessment
FXCanary’s Scam Risk Score for RCM is 51 out of 100, indicating an elevated risk profile. This score reflects the lack of regulation, limited public information, and the short operational history of the broker.
Traders should exercise extreme caution. The combination of no regulatory oversight and minimal transparency suggests a high potential for misconduct, including withdrawal issues, misappropriation of funds, or outright fraud.
Conclusion
In FXCanary’s assessment, RCM presents a high-risk proposition. Without verifiable information or regulatory oversight, there is insufficient basis to recommend this broker for any form of trading or investment.
We strongly advise traders to avoid RCM until it provides credible proof of regulation and a verifiable track record. Always prioritise brokers licensed by reputable authorities such as the FCA, ASIC, or CySEC.
Overview compiled by FXCanary from regulatory records and public data. full RCM review